Diem Nguyen to Lead Xalud Therapeutics as Chief Executive Officer
Xalud Therapeutics has named pharmaceutical industry veteran Diem Nguyen as Chief Executive Officer. He was most recently Executive Vice President with PPD. He previously served Pfizer in several executive level positions, ultimately as Global President of the Americas for Pfizer Essential Health. Earlier in his career, he held leadership roles with Serologicals and Upstate. He began his professional career as a Manager in Deloitte’s Life Sciences Consulting group.
Xalud Therapeutics is a New York City-based biotechnology company that develops therapies for the treatment of neuro-inflammatory diseases.